Sun Pharmaceutical Industries Limited : Sun Pharma to announce third quarter results on February 08, 2013

Sun Pharmaceutical Industries Ltd.

17/B, Mahal Industrial Estate, Mahakali Caves Road,

Andheri (East), Mumbai 400 093 India

Tel.: [phone]

Fax.: [phone]

FOR IMMEDIATE RELEASE Sun Pharma to announce third quarter results on February 08, 2013

January 25, 2013, Mumbai: On February 08, 2013, Sun Pharma will announce results for the third quarter ending December 31, 2012. These results will also be available on the Company website, www.sunpharma.com.

Earnings call (7.00 pm IST, February 08, 2013)

The Company will conduct an hour long call at 7 pm IST on February 08, 2013 where senior management will discuss the Company's performance and answer questions from participants. To participate in this conference call, please dial the numbers provided below five to ten minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call. You can also hear the call via an audio webcast, details of which will be announced later on the Company website, www.sunpharma.com. A transcript of this conference call will also be available on the website.

Summary of events

Event	Date and time	Telephone number/ website
Earnings release	February 08, 2013	www.sunpharma.com
Earnings conference call	7:00 pm IST, February 08, 2013	Primary Number : [phone] Secondary Number : [phone] Via audio webcast, details of which will be made available on www.sunpharma.com.
Replay of conference call	February 08, 2013 to February 15, 2013	India: [phone]. ID: #786742 Via audio webcast playback, details of which will be made available on www.sunpharma.com.

About Sun Pharmaceutical Industries Ltd.

Established in 1983, listed since 1994 and headquartered in India, Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) is an international, integrated, speciality pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world. In India, the company is a leader in niche therapy areas of psychiatry, neurology, cardiology, nephrology, gastroenterology, orthopedics and ophthalmology. The company has strong skills in product development, process chemistry, and manufacturing of

Registered Office : SPARC, Tandalja, Vadodara - 390 020. India

Corporate Office : Acme Plaza, Andheri - Kurla Road, Andheri (East), Mumbai - 400 059. India

Sun Pharmaceutical Industries Ltd.

17/B, Mahal Industrial Estate, Mahakali Caves Road,

Andheri (East), Mumbai 400 093 India

Tel.: [phone]

Fax.: [phone]

complex API, as well as dosage forms. More information about the company can be found at www.sunpharma.com.

Contacts Nimish Desai		Mira Desai
Tel	[phone], Xtn 717	Tel	[phone], Xtn 606
Tel Direct	[phone]	Tel Direct	[phone]
Mobile	[phone]	Mobile	[phone]
E mail	[e-mail]	E mail	[e-mail]

Registered Office : SPARC, Tandalja, Vadodara - 390 020. India

Corporate Office : Acme Plaza, Andheri - Kurla Road, Andheri (East), Mumbai - 400 059. India